Global Tissue Diagnostic Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Overview and Scope

Tissue diagnostic refers to a medical procedure that uses instruments to remove and stain tissue that must be sent to a laboratory or pathology department for documentation of what was excised for patient care (for tissue diagnostics). This offers measurements and descriptions, including any abnormalities, and an interpretation (or diagnosis) of health or disease status, under applicable legislation.

Sizing and Forecast

The tissue diagnostic market size has grown rapidly in recent years. It will grow from <b>$5.27 billion in 2023 to $5.92 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. </b> The growth in the historic period can be attributed to aging population, cancer prevalence, technological advancements, increased disease awareness, pathology workflow efficiency..

The tissue diagnostic market size is expected to see rapid growth in the next few years. It will grow to <b>$9.48 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. </b> The growth in the forecast period can be attributed to personalized medicine growth, rise of liquid biopsies, ai and machine learning adoption, telepathology expansion, minimally invasive techniques. Major trends in the forecast period include digital pathology, artificial intelligence (ai),telepathology services, multiplex staining and imaging, integration of genomic data..

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report 

Segmentation & Regional Insights

The tissue diagnostic market covered in this report is segmented –

1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing system

2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology And Workflow Management, Special Staining

3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)

4) By End User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations

<b>North America</b> was the largest region in the tissue diagnostic market in 2023. The regions covered in the tissue diagnostic market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6505&type=smp 

Major Driver Impacting Market Growth

The rising incidence of cancer will propel the growth of the tissue diagnostic market during the forecast period. Cancer begins when genetic changes interfere, and cells start to grow uncontrollably and destroy body tissue and form a mass called a tumor. A tumor can be cancerous or benign. Cancer can be caused due to various reasons such as genetic mutations, cancer-causing chemicals (carcinogens), smoking, obesity, radiation, hormones, and others. As the instances of occurring cancer increase, there will be a significant need for diagnostic procedures such as tissue diagnostics help in determining the disease state. For instance, according to the US voluntary health organization dedicated to eliminating cancer, the American Cancer Society, in the USA, there were expected to be 1.8 million new cancer cases identified and 606,520 cancer deaths in 2020, and the number was expected to increase to 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in 2021. Therefore, the rising incidence of cancer drives the growth of the tissue diagnostic market.

Key Industry Players

Major companies operating in the tissue diagnostic market include <b> F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Epitomics Inc., Fluidigm Corporation, GE Healthcare Technologies Inc., Genomic Health Inc., Illumina Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, Myriad Genetics Inc., NanoString Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG, CytomX Therapeutics Inc. </b>

The tissue diagnostic market report table of contents includes:

1. Executive Summary

2. Tissue DiagnosticMarket Characteristics

3.Tissue Diagnostic Market Trends And Strategies

4.Tissue Diagnostic market analysis

5.Tissue Diagnostic Market Size And Growth

6.Tissue Diagnostic Segmentation

7.Tissue Diagnostic Regional And Country Analysis

.

.

.

27Tissue Diagnostic. Competitive Landscape And Company Profiles

28.Tissue Diagnostic Key Mergers And Acquisitions

29.Tissue Diagnostic Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected] 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company 

Twitter: https://twitter.com/tbrc_info 

Facebook: https://www.facebook.com/TheBusinessResearchCompany 

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 

Blog: https://blog.tbrc.info/ 

Healthcare Blog: https://healthcareresearchreports.com/ 

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model